Phase II Trial of Docetaxel in Patients With Metastatic or Inoperable Medullary Thyroid Cancer.

Trial Profile

Phase II Trial of Docetaxel in Patients With Metastatic or Inoperable Medullary Thyroid Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Thyroid cancer
  • Focus Therapeutic Use
  • Acronyms Docetaxel-MTC
  • Most Recent Events

    • 25 Sep 2016 Status changed from recruiting to completed.
    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top